Literature DB >> 9463419

Nerve conduction block by nitric oxide that is mediated by the axonal environment.

P Shrager1, A W Custer, K Kazarinova, M N Rasband, D Mattson.   

Abstract

Conduction in rat peripheral nerve has been monitored following the stimulated release of nitric oxide (NO) from diethylamine-NONOate (DEA-NONOate). Branches of the sciatic nerve were dissected, but left otherwise intact, and propagating signals recorded externally. At levels consistent with inflammation, NO exposure resulted in a complete loss of the compound action potential. Conduction was fully restored on removal of the drug. Most notably, this loss of excitability was dependent on the axonal environment. Removal of the connective tissue sheaths surrounding the nerve bundle, a process that normally enhances drug action, prevented block of signal propagation by nitric oxide. The epineurium seemed not to be required, and the decreased susceptibility to NO appeared to be correlated with a gradual loss of a component of the endoneurium that surrounds individual fibers. Tested on the rat vagus nerve, NO eliminated action potentials in both myelinated and unmyelinated fibers. One chemical mechanism that is consistent with the reversibility of block and the observed lack of effect of 8-Br-cGMP on conduction is the formation of a nitrosothiol through reaction of NO with a sulfhydryl group. In contrast to DEA-NONOate, S-nitrosocysteine, which can both transfer nitrosonium cation (NO+) to another thiol and also release nitric oxide, was effective on both intact and desheathed preparations. It has previously been demonstrated that chemical modification of invertebrate axons by sulfhydryl-reactive compounds induces a slow inactivation of Na+ channels. Nitric oxide block of axonal conduction may contribute to clinical deficits in inflammatory diseases of the nervous system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9463419     DOI: 10.1152/jn.1998.79.2.529

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  11 in total

1.  Erythropoietin Enhanced Recovery After Traumatic Nerve Injury: Myelination and Localized Effects.

Authors:  Leigh Sundem; Kuang-Ching Chris Tseng; Haiyan Li; John Ketz; Mark Noble; John Elfar
Journal:  J Hand Surg Am       Date:  2016-09-01       Impact factor: 2.230

Review 2.  The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.

Authors:  K J Smith; W I McDonald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

3.  Exposure of rat optic nerves to nitric oxide causes protein S-nitrosation and myelin decompaction.

Authors:  Oscar A Bizzozero; Gisela DeJesus; Tamara A Howard
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

4.  Preferential conduction block of myelinated axons by nitric oxide.

Authors:  Peter Shrager; Margaret Youngman
Journal:  J Neurosci Res       Date:  2016-09-10       Impact factor: 4.164

Review 5.  Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.

Authors:  Cecilia Rajda; Dániel Pukoli; Zsuzsanna Bende; Zsófia Majláth; László Vécsei
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

Review 6.  Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy.

Authors:  Kenneth J Smith
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

Review 7.  Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation.

Authors:  Moussa A Chalah; Naji Riachi; Rechdi Ahdab; Alain Créange; Jean-Pascal Lefaucheur; Samar S Ayache
Journal:  Front Cell Neurosci       Date:  2015-11-30       Impact factor: 5.505

8.  Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis.

Authors:  Mona Sadeghian; Vincenzo Mastrolia; Ali Rezaei Haddad; Angelina Mosley; Gizem Mullali; Dimitra Schiza; Marija Sajic; Iain Hargreaves; Simon Heales; Michael R Duchen; Kenneth J Smith
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

Review 9.  Demyelination: the role of reactive oxygen and nitrogen species.

Authors:  K J Smith; R Kapoor; P A Felts
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

Review 10.  Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?

Authors:  Khalil Mallah; Christine Couch; Davis M Borucki; Amer Toutonji; Mohammed Alshareef; Stephen Tomlinson
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.